Expansion of distinct peripheral blood myeloid cell subpopulations in patients with rheumatoid arthritis-associated interstitial lung disease

• Published in: International immunopharmacology 2024-01, Vol.127, p.111330, Article 111330
• Main Authors: Poole, Jill A, Cole, Kathryn E, Thiele, Geoffrey M, Talmadge, James E, England, Bryant R, Nelson, Amy J, Gleason, Angela, Schwab, Aaron, Gaurav, Rohit, Duryee, Michael J, Bailey, Kristina L, Romberger, Debra J, Hershberger, Daniel, De Graaff, Joel Van, May, Sara M, Walenz, Rhonda, Kramer, Bridget, Mikuls, Ted R
• Format: Article
• Language: English
• Subjects: Arthritis, Rheumatoid; Humans; Idiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Monocytes; Myeloid Cells
• ISSN: 1567-5769; 1878-1705; 1878-1705
• DOI: 10.1016/j.intimp.2023.111330

Interstitial lung disease (ILD) is associated with significant mortality in rheumatoid arthritis (RA) patients with key cellular players remaining largely unknown. This study aimed to characterize inflammatory and myeloid derived suppressor cell (MDSC) subpopulations in RA-ILD as compared to RA, idiopathic pulmonary fibrosis (IPF) without autoimmunity, and controls. Peripheral blood was collected from patients with RA, RA-ILD, IPF, and controls (N = 60, 15/cohort). Myeloid cell subpopulations were identified phenotypically by flow cytometry using the following markers:CD45,CD3,CD19,CD56,CD11b,HLA-DR,CD14,CD16,CD15,CD125,CD33. Functionality of subsets were identified with intracellular arginase-1 (Arg-1) and inducible nitric oxide synthase (iNOS) expression. There was increased intermediate (CD14 CD16 ) and nonclassical (CD14 CD16 ) and decreased classical (CD14 CD16 ) monocytes in RA, RA-ILD, and IPF vs. control. Intermediate monocytes were higher and classical monocytes were lower in RA-ILD vs. RA but not IPF. Monocytic (m)MDSCs were higher in RA-ILD vs. control and RA but not IPF. Granulocytic (g)MDSCs did not significantly differ. In contrast, neutrophils were increased in IPF and RA-ILD patients with elevated expression of Arg-1 sharing similar dimensional clustering pattern. Eosinophils were increased in RA-ILD vs. controls, RA and IPF. Across cohorts, iNOS was decreased in intermediate/nonclassical monocytes but increased in mMDSCs vs. classical monocytes. In RA-ILD, iNOS positive mMDSCs were increased versus classic monocytes. Myeloid cell subpopulations are significantly modulated in RA-ILD patients with expansion of CD16 monocytes, mMDSCs, and neutrophils, a phenotypic profile more aligned with IPF than other RA patients. Eosinophil expansion was unique to RA-ILD, potentially facilitating disease pathogenesis and providing a future therapeutic target.